Department of Molecular Medicine and Surgery, Karolinska Institutet, Solna, Stockholm, Sweden.
Department of Endocrinology, Diabetes and Metabolism, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
PLoS One. 2018 Mar 13;13(3):e0193084. doi: 10.1371/journal.pone.0193084. eCollection 2018.
IGF-I is a growth factor, which is expressed in virtually all tissues. The circulating IGF-I is however derived mainly from the liver. IGF-I promotes wound healing and its levels are decreased in wounds with low regenerative potential such as diabetic wounds. However, the contribution of circulating IGF-I to wound healing is unknown. Here we investigated the role of systemic IGF-I on wound healing rate in mice with deficiency of liver-derived IGF-I (LI-IGF-I-/- mice) during normal (normoglycemic) and impaired wound healing (diabetes).
LI-IGF-I-/- mice with complete inactivation of the IGF-I gene in the hepatocytes were generated using the Cre/loxP recombination system. This resulted in a 75% reduction of circulating IGF-I. Diabetes was induced with streptozocin in both LI-IGF-I-/- and control mice. Wounds were made on the dorsum of the mice, and the wound healing rate and histology were evaluated. Serum IGF-I and GH were measured by RIA and ELISA respectively. The expression of IGF-I, IGF-II and the IGF-I receptor in the skin were evaluated by qRT-PCR. The local IGF-I protein expression in different cell types of the wounds during wound healing process was analyzed using immunohistochemistry.
The wound healing rate was similar in LI-IGF-I-/- mice to that in controls. Diabetes significantly delayed the wound healing rate in both LI-IGF-I-/- and control mice. However, no significant difference was observed between diabetic animals with normal or reduced hepatic IGF-I production. The gene expression of IGF-I, IGF-II and IGF-I receptor in skin was not different between any group of animals tested. Local IGF-I levels in the wounds were similar between of LI-IGF-I-/- and WT mice although a transient reduction of IGF-I expression in leukocytes in the wounds of LI-IGF-I-/- was observed seven days post wounding.
Deficiency in the liver-derived IGF-I does not affect wound healing in mice, neither in normoglycemic conditions nor in diabetes.
IGF-I 是一种生长因子,几乎存在于所有组织中。然而,循环中的 IGF-I 主要来源于肝脏。IGF-I 促进伤口愈合,其水平在再生潜能低的伤口(如糖尿病伤口)中降低。然而,循环 IGF-I 对伤口愈合的贡献尚不清楚。在这里,我们研究了在正常(血糖正常)和受损的伤口愈合(糖尿病)期间,肝脏源性 IGF-I 缺乏(LI-IGF-I-/- 小鼠)的小鼠中,全身性 IGF-I 对伤口愈合速度的作用。
使用 Cre/loxP 重组系统生成肝细胞中 IGF-I 基因完全失活的 LI-IGF-I-/- 小鼠,导致循环 IGF-I 减少 75%。链脲佐菌素诱导 LI-IGF-I-/- 和对照小鼠发生糖尿病。在小鼠背部制作伤口,评估伤口愈合率和组织学。用 RIA 和 ELISA 分别测量血清 IGF-I 和 GH。用 qRT-PCR 评估皮肤中 IGF-I、IGF-II 和 IGF-I 受体的表达。通过免疫组织化学分析伤口愈合过程中不同细胞类型中局部 IGF-I 蛋白的表达。
LI-IGF-I-/- 小鼠的伤口愈合率与对照组相似。糖尿病显著延迟了 LI-IGF-I-/- 和对照组小鼠的伤口愈合率。然而,在具有正常或减少的肝 IGF-I 产生的糖尿病动物之间,没有观察到显著差异。在任何一组测试的动物中,皮肤中 IGF-I、IGF-II 和 IGF-I 受体的基因表达均无差异。尽管在 LI-IGF-I-/- 小鼠的伤口中观察到白细胞中 IGF-I 表达的短暂减少,但 LI-IGF-I-/- 和 WT 小鼠伤口中的局部 IGF-I 水平相似。
肝源性 IGF-I 的缺乏不影响小鼠的伤口愈合,无论是在血糖正常的情况下还是在糖尿病中。